Biodexa Pharmaceuticals Files 6-K Report
Ticker: BDRX · Form: 6-K · Filed: May 12, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, disclosure
Related Tickers: BDRX
TL;DR
Biodexa Pharma (BDRX) filed a 6-K, standard disclosure for foreign issuers.
AI Summary
Biodexa Pharmaceuticals Plc filed a Form 6-K on May 12, 2025, reporting information for the month of May 2025. The filing indicates that the company, formerly known as Midatech Pharma Plc, is a foreign private issuer and files annual reports under Form 20-F. The company's principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Why It Matters
This filing provides routine disclosure for Biodexa Pharmaceuticals Plc as a foreign private issuer, updating the SEC on its status and reporting requirements.
Risk Assessment
Risk Level: low — This is a routine 6-K filing for a foreign private issuer, containing standard disclosure information and not indicating any immediate material changes or risks.
Key Players & Entities
- Biodexa Pharmaceuticals Plc (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- May 12, 2025 (date) — Filing date
- 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom (address) — Principal executive office
- 001-37652 (other) — SEC file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.
What was Biodexa Pharmaceuticals Plc formerly known as?
Biodexa Pharmaceuticals Plc was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
Where is Biodexa Pharmaceuticals Plc's principal executive office located?
The principal executive office of Biodexa Pharmaceuticals Plc is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
Does Biodexa Pharmaceuticals Plc file annual reports under Form 20-F?
Yes, the filing indicates by check mark that the registrant files annual reports under cover of Form 20-F.
What is the SEC file number for Biodexa Pharmaceuticals Plc?
The SEC file number for Biodexa Pharmaceuticals Plc is 001-37652.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).